Novo Nordisk Foundation will support research and development that can strengthen efforts to combat new viral infections

    The Novo Nordisk Foundation has allocated DKK 20 million to support research and development that can help Denmark to strengthen its preparedness for and response to future new viral epidemics.

    The Foundation is taking this initiative based on the global spread of the coronavirus (2019-nCoV). This not an isolated event, because several new, deadly viruses have spread in recent decades, including the viruses causing severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and Ebola.

    Under the Societal Responses to and Preparedness for Emerging Viral Infections research programme, the Foundation will award grants totalling DKK 20 million for interdisciplinary research and development projects that can strengthen Denmark’s preparedness for and response to new viral infections.

    Learn more and read how to apply here